Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
UBS
Colorcon
Chubb
Fish and Richardson
McKinsey
Harvard Business School
Moodys
Johnson and Johnson
McKesson

Generated: August 17, 2017

DrugPatentWatch Database Preview

Fougera Company Profile

« Back to Dashboard

What is the competitive landscape for FOUGERA, and when can generic versions of FOUGERA drugs launch?

FOUGERA has one hundred and nineteen approved drugs.

There is one US patent protecting FOUGERA drugs.

There are seventeen patent family members on FOUGERA drugs in fifteen countries.

Summary for Applicant: Fougera

Patents:1
Tradenames:56
Ingredients:48
NDAs:119
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fougera Pharms Inc
FLUOCINONIDE
fluocinonide
CREAM;TOPICAL200735-001Jul 14, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Fougera
BETAMETHASONE VALERATE
betamethasone valerate
OINTMENT;TOPICAL018865-001Aug 31, 1983ABRXYesYes► Subscribe► Subscribe► Subscribe
Fougera Pharms Inc
HYDROCORTISONE
hydrocortisone
CREAM;TOPICAL080693-003Approved Prior to Jan 1, 1982ATRXNoYes► Subscribe► Subscribe► Subscribe
Fougera Pharms
PREDNICARBATE
prednicarbate
CREAM;TOPICAL077287-001Sep 19, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
Fougera Pharms
SOLARAZE
diclofenac sodium
GEL;TOPICAL021005-001Oct 16, 2000ABRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Fougera

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Fougera Pharms
SOLARAZE
diclofenac sodium
GEL;TOPICAL021005-001Oct 16, 2000► Subscribe► Subscribe
Fougera Pharms
ACLOVATE
alclometasone dipropionate
OINTMENT;TOPICAL018702-001Dec 14, 1982► Subscribe► Subscribe
Fougera Pharms
TEMOVATE
clobetasol propionate
SOLUTION;TOPICAL019966-001Feb 22, 1990► Subscribe► Subscribe
Fougera Pharms
SOLARAZE
diclofenac sodium
GEL;TOPICAL021005-001Oct 16, 2000► Subscribe► Subscribe
Fougera Pharms
PANDEL
hydrocortisone probutate
CREAM;TOPICAL020453-001Feb 28, 1997► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for FOUGERA drugs

Drugname Dosage Strength Tradename Submissiondate
diclofenac sodium
Topical Gel3%
SOLARAZE
12/16/2009
fluticasone propionate
Lotion0.05%
CUTIVATE
7/28/2008

International Patent Family for Fougera Drugs

Country Document Number Estimated Expiration
United Kingdom9823036► Subscribe
China1326350► Subscribe
Australia6352499► Subscribe
Brazil9914703► Subscribe
World Intellectual Property Organization (WIPO)0024401► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Fougera Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0038France► SubscribePRODUCT NAME: ACYCLOVIR ET HYDROCORTISONE; NAT. REGISTRATION NO/DATE: NL 36 826 20100420; FIRST REGISTRATION: SK - 2108/08467-R 20091026
C/GB99/043United Kingdom► SubscribePRODUCT NAME: DORZOLAMIDE OR AN OPHTHALMOLOGICALLY ACCEPTABLE SALT THEREOF, PREFERABLY DORZOLAMIDE HYDROCHOLORIDE, PLUS TIMOLOL OR AN OPHTHAMOLOGICALLY ACCEPTABLE SALT THEREOF, PREFERABLY TIMOLOL MALEATE; REGISTERED: DK 19045 19980306; UK PL 00025/0373 19980804
C/GB08/026United Kingdom► SubscribePRODUCT NAME: FLUTICASONE FUROATE AND SOLVATES THEREOF; REGISTERED: UK EU/1/07/434/001 20080111; UK EU/1/07/434/002 20080111; UK EU/1/07/434/003 20080111
C0067France► SubscribePRODUCT NAME: AZELASTINE OU SES SELS PHARMACEUTIQUEMENT ACCEPTABLES ET UN ESTER PHARMACEUTIQUEMENT ACCEPTABLE DE FLUTICASONE; NAT. REGISTRATION NO/DATE: NL41755 20130925; FIRST REGISTRATION: SK - 24/0055/13-S 20130215
00C/001Belgium► SubscribePRODUCT NAME: DORZOLAMIDI HYDROCHLORIDUM EQ. DORZOLAMIDUM, TIMOLOLI MALEAS EQ. TIMOLOLUM; NAT. REGISTRATION NO/DATE: 922 IS 180 F 13 19981110; FIRST REGISTRATION: DK 19045 19980306
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Federal Trade Commission
Queensland Health
McKesson
Boehringer Ingelheim
QuintilesIMS
Novartis
US Department of Justice
Harvard Business School
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot